The Definitive Test: The Provocation Test

The diagnosis of allergies—whether related to food, medications, or anything else—begins with a detailed clinical history. Next, appropriate tests are conducted, such as skin prick tests or blood tests. In most cases, a combination of these two methods will determine whether a particular allergen is the problem, but in some cases, there isn’t enough information to confirm the diagnosis.

A typical example might be a young child with eczema who is at high risk for allergies but has never eaten foods such as peanuts before. After an allergy test, a very high level of antibodies may be sufficient to confirm an allergy, but when the level is only slightly elevated, we may wonder whether the child actually has an allergy.

Other scenarios include, for example, drug allergies, where a person has experienced a reaction after taking a number of different medications. Unfortunately, the value of prick skin tests and blood tests in cases of drug allergies is rather limited. Therefore, in such cases where the diagnosis is unclear, the next step is to perform an oral provocation test—the gold standard for confirming or ruling out an allergy.

An oral challenge test involves deliberately “exposing” a patient to a suspected food or medication to determine whether they are allergic to it. This usually requires some degree of medical supervision, which is why the test is performed in a hospital or a dedicated outpatient clinic or specialist clinic (depending on the type of test, the patient being tested, and the patient’s age).

In most cases, we start with a small amount of the allergen, and if no reaction occurs after 20–30 minutes, we administer a larger dose. After 4–5 subsequent exposures, if the patient has an allergy, a reaction is likely to occur. In such a case, it must be treated immediately and a diagnosis made. If, despite several exposures, no reaction is observed—and the maximum dose of the food, usually corresponding to a normal serving, appears to be tolerated—then an additional observation period of 1–2 hours is conducted before concluding the provocation test. If no reaction occurs, it can be confirmed that the patient is NOT allergic.

The two most common provocation tests are oral food provocation tests and oral drug provocation tests. Both are based on very similar principles and are conducted under a doctor’s supervision. They involve administering low doses of the suspected allergen, gradually increasing the dose, under constant, close observation.

In the case of food and drug allergies, administering a sufficiently large dose of the allergen will always cause some kind of reaction. This reaction is usually mild, but its presence confirms the diagnosis. Unfortunately, a mild reaction to an allergen challenge does not mean that subsequent reactions will also be mild, as they may occur when the patient is not in good health or when they accidentally ingest a larger amount of the allergen. Allergen provocation tests are therefore not useful for assessing the severity of an allergy, but only for determining whether an allergy is present.

Provocation tests are also performed for inhalant allergens, such as house dust mites and pollen, but this is a much less common practice. These tests can be performed using various methods, including intranasal or conjunctival provocation, in which allergens—such as dust mites—are administered into the nose (or eye), and the site of administration is then closely monitored. These tests are used to determine whether exposure to allergens will result, for example, in nasal symptoms and changes in peak nasal airflow. They can be quite uncomfortable and are therefore rarely performed, and almost never in children.

Drug challenge tests are used to determine whether a patient is allergic to a specific medication. If the risk is very low, an initial dose of 10% of the standard dose may be administered, followed by the remainder of the full dose if no reaction occurs within approximately 30 minutes. The observation period lasts 1–2 hours.

If there is an increased risk that the medication will trigger a reaction, a series of smaller doses may be administered. It is best to maintain approximately 30-minute intervals between doses to closely monitor for any signs of a reaction. After the last dose is administered, there is another 1–2-hour observation period before the challenge test is concluded. If a reaction occurs at any time, an allergy can be confirmed; if not, it can be ruled out, and the medication can be safely used in the future.

Food provocation tests generally take two forms, depending on the likelihood of an allergic reaction.

• In cases where an allergic reaction is considered unlikely or is expected to be mild, the challenge test is conducted as a “supervised feeding.” This involves asking the patient to eat a normal portion of the food and then observing them for 1–2 hours for signs of an allergic reaction. This approach is common, for example, when a patient is allergic to one type of nut—such as peanuts—and has very low levels of antibodies to other nuts. Supervised feeding helps confirm that other nuts are safe to include in the diet.
• If the risk is considered slightly higher, a gradual oral food challenge is performed. This method ensures that a reaction will be detected only after consuming an amount greater than the one to which the patient is allergic, and is believed to reduce the risk of more severe reactions.

Most often, an open challenge test is performed, in which the patient knows what they are consuming. Gradually increasing portions of the food are administered, and observation continues for at least two hours. If the risk of misinterpretation is higher, a single-blind test is used (the patient does not know what they are receiving, but the doctor does).

However, the gold standard is the double-blind challenge (DBPCFC), in which neither the patient nor the doctor knows whether the food being administered is the allergen or a placebo. Two sessions are conducted—one with the product and one with the placebo—preferably on different days.

The food should be in the same form in which it previously caused symptoms (e.g., raw milk, boiled egg). For children with a milk allergy, a so-called “milk muffin”—that is, heat-treated proteins—can be used, as these are often better tolerated.

The dose of the product depends on the type of reaction.

• In immediate IgE-mediated reactions, treatment begins with a microdose (0.15–0.3 g of protein/kg of body weight), which is increased every 15–30 minutes.
• If the patient has a history of severe reactions (e.g., anaphylactic shock), the initial dose should be lower.
• If non-IgE-mediated reactions are suspected (with delayed onset of symptoms), the intervals between doses may be extended to 45 minutes. Observation after the test ends lasts at least 2 hours, and sometimes up to 24 hours in the case of delayed reactions.
• For infants, milk or infant formula is used; for older children and adults, solid foods are used.

Positive result: Indicates an intolerance to the food in question. The patient should continue to exclude it from their diet and receive a plan of action in the event of an anaphylactic reaction. A repeat test may be considered after 6–12 months, or after 2–3 years in the case of severe reactions.

Negative result: Allows the food to be reintroduced into the diet in a form comparable to that used during the test.

An oral food challenge is the most accurate test for diagnosing food allergies. It allows us to confirm or rule out an allergy and determine the tolerance threshold. A negative result makes it possible to expand the patient’s diet and improve their quality of life.

Allergic reactions are unpredictable and may be more severe than expected. Therefore, allergen challenge tests are used only when necessary—that is, when allergy tests and a clinical history do not provide clear answers. However, there are certain factors that help ensure safety. Provocation tests are conducted:

• only under a doctor’s supervision, by staff experienced in identifying and quickly treating allergic reactions. Medical personnel have access to appropriate monitoring equipment and, most importantly, adrenaline in injectable form to enable rapid treatment of severe reactions,
• only when the patient is in good health, which significantly reduces the risk,
• using escalating doses with observation periods in between, which ensures that a reaction occurs when the smallest dose to which the patient is sensitive is administered.

Food and drug challenge tests are routinely performed in specialized allergy clinics around the world and are considered safe, provided they are conducted by experienced specialists in an appropriate setting where allergic reactions can be quickly recognized and treated appropriately. Treatment typically involves the use of antihistamines and observation, but it is crucial to ensure immediate access to epinephrine injections in the unlikely event that they are needed, and that they can be administered by personnel experienced in treating severe allergic reactions. However, even if a reaction occurs, the vast majority of provocation tests require only minimal medical intervention.

Before the test, the patient should be informed about possible adverse reactions and what to do if they occur. The test should be stopped immediately upon the appearance of the first symptomatic reactions, and appropriate treatment should be initiated: epinephrine, systemic steroids, antihistamines, and oxygen therapy.

Before performing the challenge test, assess the risk of a severe reaction—especially if there is a history of respiratory or cardiovascular reactions, strongly positive sIgE/SPT tests, sensitization to multiple allergens (e.g., nuts, fish, shellfish, milk), and coexisting asthma. Mild reactions, a long symptom-free period, and favorable test results are considered low-risk factors. High risk is associated with severe reactions within the past 6–12 months. It is important to remember that high IgE levels do not always indicate intolerance—the decision depends on the clinical context.

To undergo an oral provocation test, you should consult an allergist, who, after conducting a detailed medical history, will assess the potential risks, the appropriateness of the test, and the location where it should be performed.

• High-risk tests are performed in a hospital setting—in an intensive care unit with access to resuscitation equipment.
• If the risk is low, the test can be performed on an outpatient basis, but always under strict medical supervision, with the ability to monitor the patient and administer anti-shock medications immediately.

The patient must understand the purpose and risks of the oral provocation test and sign a written consent form. The test may only be performed on a healthy individual—an acute infection or fever precludes participation in the test. Chronic conditions, including asthma, must be well-controlled. Pregnancy is a contraindication for the test.

The patient should fast for 2–4 hours (shorter for children) and discontinue any medications that may affect the safety or reliability of the results.

Before an oral food challenge (OFC), the following medications should be discontinued:

• antihistamines – 3–10 days before the test,
• systemic steroids – 7–14 days,
• tricyclic and atypical antidepressants and benzodiazepines – 3 days to 3 weeks,
• proton pump inhibitors (PPIs) – 1 day,
• bronchodilators:
  • short-acting (e.g., salbutamol) – 24 hours,
  • long-acting (e.g., formoterol, salmeterol) – 48 hours,
  • ipratropium bromide – 24 hours.

The simultaneous use of beta-blockers and ACE inhibitors may exacerbate allergic reactions, although this effect may depend on the patient’s coexisting diseases and age.

In patients with atopic dermatitis, the food being tested should be eliminated from the diet for at least two weeks. This is enough time to observe a reaction during the test, even if no symptoms have previously occurred after consuming that food.

An oral provocation test is a high-risk procedure that can trigger a severe allergic reaction or even anaphylactic shock; therefore, it should be performed only at centers with experience in diagnosing and treating anaphylactic reactions.

However, it is sometimes necessary when only a definitive diagnosis can prevent chronic symptoms or the unnecessary exclusion of important foods from the diet, which could lead to nutritional deficiencies. Currently available diagnostic tests (e.g., sIgE, SPT) are simpler and safer, but they do not always allow for unequivocal confirmation or exclusion of an allergy. This is precisely why the oral food challenge remains the gold standard in the diagnosis of food allergies, provided it is performed under appropriate conditions and under the supervision of qualified personnel.